Related Articles
Novel synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statins
Effects of an HMG-CoA reductase inhibitor, simvastatin, on human myeloma cells
Potential antitumor effects of statins (Review)
Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice
Statins induce apoptosis and inhibit proliferation in cholangiocarcinoma cells